Product Information

INVOKAMET 150-1,000 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $9.5505 per EA under NDC 50458054360. Its NADAC has been published 626 times since Nov 19, 2014.

FDA first approved this application on Aug 8, 2014.

INVOKAMET 150-1,000 MG TABLET

canagliflozin and metformin hydrochloride
$9.5505per EA

Strength

150; 1000 mg/1; mg/1

NDC

50458054360

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

New Drug (NDA)

FDA Application

NDA204353

FDA Approved

8/8/2014

On Market Since

8/8/2014

Pharmacological Classes

Biguanide
Biguanides
P-Glycoprotein Inhibitors
Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

Price Statistics

The NADAC for INVOKAMET 150-1,000 MG TABLET has been published 626 times since Nov 19, 2014, and over the history we have for it it has risen 91.1%. The table below summarizes its recorded NADAC range and movement.

Current price$9.5505 per EA
All-time high$9.5957 (Feb 12, 2025)
All-time low$4.9970 (Nov 19, 2014)
52-week high$9.5844
52-week low$9.5505
Median price$8.3436
Average price$8.1223
Largest weekly change+9.9% (Feb 11, 2015)
Weeks tracked626
Tracking sinceNov 19, 2014

Price History

1W

0.0%

1M

-0.3%

3M

-0.2%

6M

-0.2%

1Y

-0.4%

3Y

+0.1%

5Y

+10.2%

All

+91.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 0%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of INVOKAMET 150-1,000 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for INVOKAMET 150-1,000 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $9.5505 per EA (NDC 50458054360), effective Nov 11, 2026.

How has the price of INVOKAMET 150-1,000 MG TABLET changed over time?

Over the history we have for it, the NADAC for INVOKAMET 150-1,000 MG TABLET has risen 91.1%. It has been tracked across 626 weekly CMS publications since Nov 19, 2014.

What are the highest and lowest recorded NADAC prices for INVOKAMET 150-1,000 MG TABLET?

Since Nov 19, 2014, the NADAC for INVOKAMET 150-1,000 MG TABLET has ranged from a low of $4.9970 (Nov 19, 2014) to a high of $9.5957 (Feb 12, 2025), with a median of $8.3436 per EA.

Are there cheaper alternatives to INVOKAMET 150-1,000 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INVOKAMET XR 150-1,000 MG TAB, is $9.5184 per EA — about 0% below INVOKAMET 150-1,000 MG TABLET.

Who manufactures INVOKAMET 150-1,000 MG TABLET?

INVOKAMET 150-1,000 MG TABLET (NDC 50458054360) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.